Company Filing History:
Years Active: 2003
Title: Innovations of Joo-Sun Son in Paclitaxel Production
Introduction
Joo-Sun Son is a notable inventor based in Daejon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the mass production of paclitaxel, a vital compound used in cancer treatment. His innovative methods have the potential to enhance the efficiency of paclitaxel production, making it more accessible for industrial applications.
Latest Patents
Joo-Sun Son holds a patent for a method that increases the production level of paclitaxel by altering the temperature during plant cell culture. The patent describes a procedure that involves cultivating Taxus genus plant cells in a medium at approximately 20 to 25 degrees Celsius. Once the plant cells have sufficiently grown, the cultivation temperature is adjusted to around 26 to 32 degrees Celsius to continue the culture. This method also includes inoculating the cells at a high initial concentration and increasing the saccharide concentration in the medium. The invention allows for the convenient mass production of paclitaxel, highlighting its industrial applicability.
Career Highlights
Joo-Sun Son is associated with Samyang Genex Corporation, where he continues to develop innovative solutions in biotechnology. His work has garnered attention for its practical implications in the pharmaceutical industry, particularly in cancer treatment.
Collaborations
He collaborates with notable colleagues, including Ho-Joon Choi and Hyung-Kyoon Choi, who contribute to the advancement of research and development in their field.
Conclusion
Joo-Sun Son's contributions to the mass production of paclitaxel represent a significant advancement in biotechnology. His innovative methods not only enhance production efficiency but also hold promise for improving cancer treatment accessibility.